Literature DB >> 23635590

Predicting early cancer-related deaths after curative esophagectomy for esophageal cancer.

Sohei Matsumoto1, Tomoyoshi Takayama, Kohei Wakatsuki, Koji Enomoto, Tetsuya Tanaka, Kazuhiro Migita, Masahiro Ito, Yoshiyuki Nakajima.   

Abstract

Esophagectomy is the primary treatment for esophageal cancers, but a few patients still suffer from early recurrence and die within one year after surgery. The aim of this study was to identify preoperative predictive risk factors for early cancer-related deaths after curative esophagectomy for esophageal squamous cell carcinoma. The records of 200 consecutive patients with esophageal cancer who underwent esophagectomy between 1990 and 2009 were retrospectively reviewed. The preoperative clinical characteristics of the remaining 32 patients who died of cancer within one year were compared with those of 168 patients who survived for more than one year postsurgery. The most frequent cause of death was lymph node recurrence followed by local recurrence and lung metastases. A tumor size 60 mm or greater and lymph node metastases in two fields on preoperative imaging were identified as prognostic factors on multivariate analysis. The one-year survival rate and median survival time of patients with both these risk factors were 40 per cent and 12 months, respectively. Aggressive additional treatment may be needed if both a tumor size 60 mm or greater and lymph node metastases in two fields are found during diagnostic imaging before esophagectomy for esophageal squamous cell carcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 23635590

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  1 in total

1.  Esophagectomy for cancer in octogenarians: should we do it?

Authors:  Elizabeth Paulus; Caroline Ripat; Vadim Koshenkov; Angela T Prescott; Kiran Sethi; Heather Stuart; Gregory Tiesi; Alan S Livingstone; Danny Yakoub
Journal:  Langenbecks Arch Surg       Date:  2017-03-16       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.